Neesgaard, Bastian, Pelchen-Matthews, Annegret ORCID: 0000-0002-0994-5655, Ryom, Lene, Florence, Eric, Peters, Lars, Roen, Ashley, Svedhem, Veronika, Clarke, Amanda, Benfield, Thomas ORCID: 0000-0003-0698-9385, Mitsura, Viktar, Moreno, Santiago, Beniowski, Marek, Begovac, Josip, Matulionyte, Raimonda, Trofimova, Tatyana, Elbirt, Daniel, Kundro, Mariana, Vullo, Vincenzo, Behrens, Georg, Staub, Therese, Ragone, Leigh, Vannappagari, Vani, Lundgren, Jens, Mocroft, Amanda, Schmied, B., Zangerle, R., Karpov, I., Vassilenko, A., Paduto, D., Clumeck, N., De Wit, S., Delforge, M., Vandekerckhove, L., Hadziosmanovic, V., Machala, L., Jilich, D., Sedlacek, D., Kronborg, G., Benfield, T., Gerstoft, J., Katzenstein, T., Pedersen, C., Johansen, I. S., Ostergaard, L., Wiese, L., Moller, N. F., Nielsen, L. N., Zilmer, K., Smidt, Jelena, Ristola, M., Aho, I., Viard, J. -P., Girard, P. -M., Pradier, C., Fontas, E., Duvivier, C., Rockstroh, J., Degen, O., Stellbrink, H. J., Stefan, C., Goethe, J. W., Bogner, J., Faetkenheuer, G., Chkhartishvili, N., Sambatakou, H., Adamis, G., Paissios, N., Szlavik, J., Gottfredsson, M., Mulcahy, F., Yust, I., Turner, D., Burke, M., Shahar, E., Hassoun, G., Elinav, H., Haouzi, M., Sthoeger, Z. M., Monforte, A. D'Arminio, Esposito, R., Mazeu, I., Mussini, C., Mazzotta, F., Gabbuti, A., Lichtner, M., Zaccarelli, M., Antinori, A., Acinapura, R., Plazzi, M., Lazzarin, A., Castagna, A., Gianotti, N., Galli, M., Ridolfo, A., Rozentale, B., Uzdaviniene, V., Hemmer, R., Reiss, P., Reikvam, D. H., Maeland, A., Bruun, J., Knysz, B., Gasiorowski, J., Inglot, M., Bakowska, E., Flisiak, R., Grzeszczuk, A., Parczewski, M., Maciejewska, K., Aksak-Was, B., Mularska, E., Smiatacz, T., Gensing, M., Jablonowska, E., Kamerys, J., Wojcik, K., Mozer-Lisewska, I., Rozplochowski, B., Caldeira, L., Mansinho, K., Maltez, F., Radoi, R., Oprea, C., Panteleev, A., Panteleev, O., Yakovlev, A., Trofimora, T., Khromova, I., Kuzovatova, E., Borodulina, E., Vdoushkina, E., Miro, J. M., Mallolas, J., Martinez, E., Garcia, F., Blanco, J. L., Laguno, M., Martinez-Rebollar, M., del Campo, S., Clotet, B., Jou, A., Paredes, R., Puig, J., Llibre, J. M., Santos, J. R., Domingo, P., Gutierrez, M., Mateo, G., Sambeat, M. A., Laporte, J. M., Falconer, K., Thalme, A., Sonnerborg, A., Treutiger, C. J., Flamholc, L., Scherrer, A., Weber, R., Cavassini, M., Calmy, A., Furrer, H., Battegay, M., Schmid, P., Kuznetsova, A., Kyselyova, G., Sluzhynska, M., Gazzard, B., Johnson, A. M., Simons, E., Edwards, S., Phillips, A., Johnson, M. A., Orkin, C., Weber, J., Scullard, G., Leen, C., Phillips, A., Cozzi-Lepri, A., Shepherd, L., Amele, S., Karpov, I., Losso, M., Rockstroh, J., Aho, I., Rasmussen, L. D., Svedhem, V., Wandeler, G., Pradier, C., Chkhartishvili, N., Oprea, C., Kowalska, J. D., Guaraldi, G. and Paredes, R. (2019). Uptake and effectiveness of two-drug compared with three-drug antiretroviral regimens among HIV-positive individuals in Europe. Aids, 33 (13). S. 2013 - 2025. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1473-5571

Full text not available from this repository.

Abstract

Objective: To assess the use of two-drug antiretroviral regimens (2DR) and virologic and immunologic outcomes compared with three-drug regimens (3DR) in the EuroSIDA cohort. Design: Multicentre, prospective cohort study. Methods: Logistic regression was used to analyse the uptake and outcomes among HIV-positive individuals who started or switched to a 2DR compared with those on a 3DR. Virologic outcomes were assessed on-treatment as the proportion of individuals with controlled viral load (<400 copies/ml), or with a composite modified FDA snapshot endpoint (mFDA), with mFDA success defined as controlled viral load at 6 months or 12 months for individuals with a known viral load, no regimen changes, AIDS or death. Immunologic response was defined as a 100 cells/mu l or a 25% increase in CD4(+) cell counts from baseline. Results: Between 1 July 2010 and 31 December 2016, 423 individuals started or switched to a 2DR (eight antiretroviral-naive) and 4347 started a 3DR (566 naive). Individuals on 2DR tended to have suppressed viral load, higher CD4(+) cell counts and more comorbidities at baseline compared with those on 3DR. There were no differences in the proportions of individuals who obtained on-treatment or mFDA success, and no significant differences in the adjusted odds ratios for mFDA success or immunologic responses between the 2DR and 3DR groups at 6 months or 12 months. Conclusion: In routine clinical practice, 2DR were largely used for virologically suppressed individuals with higher cumulative exposure to antiretrovirals and comorbidities. Virologic and immunologic outcomes were similar among those on 2DR or 3DR, although confounding by indication cannot be fully excluded due to the observational nature of the study.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Neesgaard, BastianUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Pelchen-Matthews, AnnegretUNSPECIFIEDorcid.org/0000-0002-0994-5655UNSPECIFIED
Ryom, LeneUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Florence, EricUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Peters, LarsUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Roen, AshleyUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Svedhem, VeronikaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Clarke, AmandaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Benfield, ThomasUNSPECIFIEDorcid.org/0000-0003-0698-9385UNSPECIFIED
Mitsura, ViktarUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Moreno, SantiagoUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Beniowski, MarekUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Begovac, JosipUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Matulionyte, RaimondaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Trofimova, TatyanaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Elbirt, DanielUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kundro, MarianaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Vullo, VincenzoUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Behrens, GeorgUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Staub, ThereseUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Ragone, LeighUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Vannappagari, VaniUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Lundgren, JensUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Mocroft, AmandaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schmied, B.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Zangerle, R.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Karpov, I.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Vassilenko, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Paduto, D.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Clumeck, N.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
De Wit, S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Delforge, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Vandekerckhove, L.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hadziosmanovic, V.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Machala, L.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Jilich, D.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Sedlacek, D.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kronborg, G.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Benfield, T.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gerstoft, J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Katzenstein, T.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Pedersen, C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Johansen, I. S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Ostergaard, L.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wiese, L.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Moller, N. F.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Nielsen, L. N.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Zilmer, K.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Smidt, JelenaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Ristola, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Aho, I.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Viard, J. -P.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Girard, P. -M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Pradier, C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Fontas, E.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Duvivier, C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Rockstroh, J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Degen, O.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Stellbrink, H. J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Stefan, C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Goethe, J. W.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bogner, J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Faetkenheuer, G.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Chkhartishvili, N.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Sambatakou, H.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Adamis, G.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Paissios, N.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Szlavik, J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gottfredsson, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Mulcahy, F.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Yust, I.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Turner, D.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Burke, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Shahar, E.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hassoun, G.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Elinav, H.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Haouzi, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Sthoeger, Z. M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Monforte, A. D'ArminioUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Esposito, R.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Mazeu, I.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Mussini, C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Mazzotta, F.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gabbuti, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Lichtner, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Zaccarelli, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Antinori, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Acinapura, R.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Plazzi, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Lazzarin, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Castagna, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gianotti, N.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Galli, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Ridolfo, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Rozentale, B.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Uzdaviniene, V.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hemmer, R.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Reiss, P.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Reikvam, D. H.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Maeland, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bruun, J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Knysz, B.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gasiorowski, J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Inglot, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bakowska, E.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Flisiak, R.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Grzeszczuk, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Parczewski, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Maciejewska, K.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Aksak-Was, B.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Mularska, E.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Smiatacz, T.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gensing, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Jablonowska, E.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kamerys, J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wojcik, K.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Mozer-Lisewska, I.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Rozplochowski, B.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Caldeira, L.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Mansinho, K.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Maltez, F.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Radoi, R.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Oprea, C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Panteleev, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Panteleev, O.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Yakovlev, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Trofimora, T.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Khromova, I.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kuzovatova, E.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Borodulina, E.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Vdoushkina, E.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Miro, J. M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Mallolas, J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Martinez, E.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Garcia, F.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Blanco, J. L.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Laguno, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Martinez-Rebollar, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
del Campo, S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Clotet, B.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Jou, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Paredes, R.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Puig, J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Llibre, J. M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Santos, J. R.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Domingo, P.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gutierrez, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Mateo, G.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Sambeat, M. A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Laporte, J. M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Falconer, K.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Thalme, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Sonnerborg, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Treutiger, C. J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Flamholc, L.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Scherrer, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Weber, R.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Cavassini, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Calmy, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Furrer, H.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Battegay, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schmid, P.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kuznetsova, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kyselyova, G.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Sluzhynska, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gazzard, B.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Johnson, A. M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Simons, E.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Edwards, S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Phillips, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Johnson, M. A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Orkin, C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Weber, J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Scullard, G.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Leen, C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Phillips, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Cozzi-Lepri, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Shepherd, L.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Amele, S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Karpov, I.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Losso, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Rockstroh, J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Aho, I.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Rasmussen, L. D.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Svedhem, V.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wandeler, G.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Pradier, C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Chkhartishvili, N.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Oprea, C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kowalska, J. D.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Guaraldi, G.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Paredes, R.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-128536
DOI: 10.1097/QAD.0000000000002320
Journal or Publication Title: Aids
Volume: 33
Number: 13
Page Range: S. 2013 - 2025
Date: 2019
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Place of Publication: PHILADELPHIA
ISSN: 1473-5571
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
ATAZANAVIR/RITONAVIR PLUS LAMIVUDINE; REVERSE-TRANSCRIPTASE INHIBITOR; OPEN-LABEL; RANDOMIZED-TRIAL; NON-INFERIORITY; INFECTED PATIENTS; TRIPLE THERAPY; DUAL THERAPY; EMTRICITABINE; MAINTENANCEMultiple languages
Immunology; Infectious Diseases; VirologyMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/12853

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item